Gopal Grandhige, MD, FACS, Board-Certified Surgeon Last Reviewed: April 20, 2026 BPC-157 has a half-life of approximately 4 to 6 hours when administered via subcutaneous injection, so the peptide itself clears your system relatively quickly
doi:10.1146/annurev.nu.05.070185.000555
Specifically, neurological disorders often present with chronic inflammation and oxidative stress that may benefit from higher sulforaphane doses
Supplementing may be even more important for those with compromised immunity
METHOD: Solvent Casting Method Fig
10.1111/pan.14307 Summary Keywords developmental pharmacology, intranasal sedation, neonatal pain management, neonatal sedation, opioid-sparing strategies, pharmacological analgesia, pharmacological sedation Citation Cavallaro G, Garrido F, Decembrino N, Bullejos Garcia EE and Raffaeli G (2026) Pharmacological therapy of neonatal analgosedation: current status, dilemmas, and perspectives